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Summary
 
In the principal pathway of 
 
a
 
/
 
b
 
 T cell maturation, T cell precursors from the bone marrow
migrate to the thymus and proceed through several well-characterized developmental stages
into mature CD4
 
1
 
 and CD8
 
1
 
 T cells. This study demonstrates an alternative pathway in which
the bone marrow microenvironment also supports the differentiation of T cell precursors into
CD4
 
1
 
 and CD8
 
1
 
 T cells. The marrow pathway recapitulates developmental stages of thymic
maturation including a CD4
 
1
 
CD8
 
1
 
 intermediary cell and positive and negative selection, and
is strongly inhibited by the presence of mature T cells. The contribution of the marrow path-
way in vivo requires further study in mice with normal and deficient thymic or immune func-
tion.
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S
 
ince the landmark discoveries that lymphocytes initiate
cellular immune responses and that the thymus is the
principal source of these immune cells, the maturation of
lymphocytes in the thymus has been studied extensively,
and the principal intermediary stages of development have
been identified (1, 2). 
 
a
 
/
 
b
 
 T cell precursors emigrate from
the bone marrow to the thymus and the earliest precursors
in the thymus do not express the CD4, CD8, or CD3 sur-
face receptors, and have not rearranged the TCR-
 
a
 
 or -
 
b
 
chain genes (3–5). Shortly after the latter genes are rear-
ranged during thymic maturation, the predominant inter-
mediary CD4
 
1
 
CD8
 
1
 
 (double positive) T cells develop and
give rise to CD4
 
1
 
 and CD8
 
1
 
 (single positive) 
 
a
 
/
 
b
 
 T cells
via processes of positive and negative selection (6–9). The
latter cells emigrate to the periphery and, after stimulation
by antigen, generate effector cells of cell-mediated immu-
nity or helper cells that regulate humoral immunity (10,
11). The predominance of the thymus in T cell maturation
is thought to be related to its unique stromal microenviron-
ment, which has been shown to support differentiation in
vitro in thymic organ cultures or in heterogeneous thymic
stromal cell cultures (12–14).
Extrathymic maturation of T cells also occurs, and con-
tributes to the pool of T cells in the lymph nodes, spleen,
marrow, liver, and intestines of athymic nude mice and
thymectomized lethally irradiated mice injected with a
source of hematopoietic progenitor cells (15–19). The ex-
pression of the genes encoding the recombinase enzymes
recombination-activating gene (RAG)-1 and RAG-2, as well
as the presence of circular DNA products of TCR-
 
a
 
 chain
gene rearrangements, indicate that T cell development oc-
curs in several extrathymic sites, including the bone mar-
row, adult and fetal liver, and yolk sac (20, 21).
The nature of the extrathymic microenvironments that
support T cell maturation and the intermediate stages of
maturation in these sites are presently unknown. Previous
studies have shown that T cell–depleted cultures of single
cell suspensions of bone marrow from euthymic and athy-
mic mice and from thymectomized, lethally irradiated mice
reconstituted with stem cells are capable of generating T
cells in vitro (19, 22–24). In this study, we show that these
bone marrow cultures can give rise to 
 
a
 
/
 
b
 
 T cells with the
mature CD4
 
1
 
CD8
 
2
 
 and CD4
 
2
 
CD8
 
1
 
 surface phenotype
via a CD4
 
1
 
CD8
 
1
 
 intermediary stage that recapitulates the
principal features of thymic maturation, including negative
selection of autoreactive cells. Although the marrow mi-
croenvironment is able to support the maturation of T
cells, the presence of mature T cells strongly inhibits the
process, and the marrow must be stringently depleted of
the latter cells in order to observe the process. These results
indicate that T cell production might be under complex
homeostatic controls that regulate the differentiation of T
cell precursors in the marrow and thymic pathways.
 
M.E. García-Ojeda and S. Dejbakhsh-Jones contributed equally to the re-
search described in this paper.
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Materials and Methods
 
Animals.
 
C57BL/6 (Ly5.1,Thy1.2), congenic C57BL/6
Ly5.2 (Ly5.2,Thy1.1), C57BL/Ka, and BALB/c male and female
mice, 6–8 wk of age, were obtained from a colony maintained in
the Department of Comparative Medicine, Stanford University
(Stanford, CA). SWR/J mice were purchased from The Jackson
Laboratories (Bar Harbor, ME).
 
Antibodies.
 
The following monoclonal antibodies used in im-
munofluorescent staining were purified and conjugated to FITC
as previously described (14): KT31.1 (anti-CD3); 6B2 (anti-
B220, CD45R); GK1.5 (anti-CD4); 53-6.7 (anti-CD8
 
a
 
); Ter119
(anti-erythrocyte lineage); 136TC (anti-NK1.1); MR10-2 (anti-
TCRV
 
b
 
9); A20.1.7 (anti-Ly5.2, CD45.1); and M1/69 (anti–heat-
stable antigen [HSA], CD24).
 
1
 
 Some antibodies were conjugated
to PE: GK1.5, 53-6.7 (anti-CD8
 
a
 
); M1/70 (anti-Mac1, CD11b);
and 6B2. Others were conjugated to allophycocyanin: IM781 (anti-
CD44); 53-7.3 (anti-CD5); 2B8 (anti-cKit, CD117); H57-597
(anti–TCR-
 
a
 
/
 
b
 
); and 6B2; or were conjugated to biotin: KT31.1;
MEL-14 (anti–L-selectin, CD62L); AL1-4A2 (anti-Ly5.1, CD45.2);
E13-161 (anti-Sca1); 19XE5 (anti-Thy1.1, CD90.1); and 6B2.
Monoclonal FITC-conjugated antibodies H57-597, KJ23 (anti-
TCRV
 
b
 
17), 7D4 (anti-CD25), H1.2F3 (anti-CD69), MR11-1
(anti-TCRV
 
b
 
12), AB20.6 (anti-TCRV
 
b
 
2), KT4 (anti-TCRV
 
b
 
4),
MR9-4 (anti-TCRV
 
b
 
5.1/5.2), RR3-15 (anti-TCRV
 
b
 
11), RR4-7
(anti-TCRV
 
b
 
6), TR310 (anti-TCRV
 
b
 
7), and MR5-2 (anti-
TCRV
 
b
 
8.1/8.2) were obtained from PharMingen (San Diego,
CA). Antibodies conjugated to biotin (H57-597, M1/69, KJ25
[anti-TCRV
 
b
 
3], 2.4G2 [anti-CD16/32], RM2-5 [anti-CD2],
53-5.8 [anti-CD8
 
b
 
]), or to PE (RB6-8C3 [anti-GR1] and
PK136 [anti-NK1.1]) were also obtained from PharMingen. The
following additional PE-conjugated antibodies were acquired
from Caltag (South San Francisco, CA): YTS191.1 (anti-CD4);
CT-CD8a (anti-CD8
 
a
 
); and 5a-8 (anti-Thy1.2, CD90.2). The
isotype control hamster IgG-FITC and rat IgG2b-PE were also
purchased from Caltag. Biotinylated antibodies were counter-
stained with streptavidin reagents conjugated to either allophyco-
cyanin, Texas red, or PE, all purchased from Caltag. 30H12 (anti-
Thy1.2) conjugated to FITC was purchased from Becton Dickin-
son (Mountain View, CA).
 
Cell Preparation and Immunofluorescent Staining.
 
Single cell sus-
pensions of spleen and bone marrow cells were obtained as previ-
ously described (22). Fresh single cell suspensions were incubated
with various combinations of fluorochrome- or biotin-conju-
gated antibodies at saturation for 30 min on ice. In the case of bi-
otin-conjugated reagents, counterstaining for 15 min with fluoro-
chrome-conjugated streptavidin was performed. After staining,
cells were washed and resuspended in fresh medium containing
PBS without calcium or magnesium (Biowhittaker, Walkersville,
MA) with 1% fetal bovine serum (FBS; Hyclone, Logan, UT) be-
fore sorting or analysis.
Cultured bone marrow samples were stained as described
above, except that cells were pretreated with unconjugated anti-
CD16/32 mAb at saturation to block Fc
 
g
 
RIIIA/B receptors.
Stained samples were resuspended in staining media (calcium- and
magnesium-free PBS containing 1% FBS, 0.05% NaN
 
3
 
 [Fisher
Scientific Co., Fair Lawn, NJ]) with propidium iodide at 0.5 
 
m
 
g/ml
(Sigma Chemical Co., St. Louis, MO). In all instances, cells were
gated to exclude those stained with propidium iodide (dead cells).
 
Cell Sorting and FACS
 
Ò
 
 Analysis.
 
All fresh and cultured mar-
row samples were gated by light scatter and propidium iodide up-
take to exclude dead cells and erythrocytes from the analysis of
fluorochrome staining or from cell sorting. Sorting of stained
bone marrow cells to stringently deplete T cells was performed
using a FACStar
 
Ò
 
 (Becton Dickinson, Mountain View, CA).
Thresholds for TCR-
 
a
 
/
 
b
 
2
 
, CD4
 
2
 
, and CD8
 
2
 
 populations were
set 10 channels below the background staining channels obtained
with isotype control antibodies. To enhance purity of TCR-
 
a
 
/
 
b
 
1
 
 and TCR-
 
a
 
/
 
b
 
2
 
 populations, a 20-channel gap was placed
between the sorted cells. Cells falling in the gap were discarded.
Reanalysis was performed on all sorted samples to ensure their
purity.
Four-color FACS
 
Ò
 
 analysis was done using a highly modified
dual laser (488-nm argon and 599-nm dye lasers), FACS
 
Ò
 
 III
(Becton Dickinson) with four-decade logarithmic amplifiers (25).
One- to three-color sorting was done in the FACStar
 
Ò
 
 (Becton
Dickinson). Data was analyzed using FACS
 
Ò
 
/DESK software as
either histograms or two-parameter 5% probability plots.
 
Bone Marrow Cell Cultures.
 
T cell–depleted bone marrow
cells were cultured in RPMI-1640 (Biowhittaker) supplemented
with 10% FBS (Hyclone), penicillin/streptomycin (Biowhit-
taker), glutamine (Biowhittaker), and 2-mercaptoethanol (GIBCO
BRL, Bethesda, MD). 4–8 
 
3
 
 10
 
6
 
 sorted cells were cultured at
37
 
8
 
C, for up to 48 h in a humidified incubator with 5% CO
 
2
 
 in a
vented, upright T12.5 flask (Falcon, Franklin Lakes, NJ) at 2 
 
3
 
10
 
6
 
 cells/ml. For time course analysis, the culture was stopped at
the indicated time. At the end of the culture period, cells were
harvested and washed twice in staining medium before immuno-
fluorescent staining. The nucleated cell yields of all cultures in-
cluded in the Tables and Figures were at least 80%, but did not
exceed the input cell number.
 
Results
 
Outgrowth of CD4
 
1
 
 and CD8
 
1
 
 
 
a
 
/
 
b
 
 T Cells from Bone Mar-
row Cultures.
 
Previous studies showed that T cell–depleted
cultures of bone marrow cells from a variety of euthymic
and athymic mice generated CD4
 
2
 
CD8
 
2
 
 
 
a
 
/
 
b
 
 T cells after
a 48-h incubation in tissue culture medium, supplemented
with FBS but without growth factors (19, 23). In this
study, use of the same culture system with an appropriate
source of FBS generated CD4
 
1
 
 and CD8
 
1
 
 
 
a
 
/
 
b
 
 T cells
without CD4
 
2
 
CD8
 
2
 
 
 
a
 
/
 
b
 
 T cells as shown in Fig. 1. Fresh
C57BL/Ka marrow cells were stringently depleted of cells
expressing CD4, CD8, and TCR-
 
a
 
/
 
b
 
 markers by immu-
nofluorescent staining and flow cytometry. Fig. 1 
 
A
 
 shows
the staining pattern of the marrow cells using PE-conju-
gated anti-CD4 and anti-CD8 monoclonal antibodies, and
FITC-conjugated anti–TCR-
 
a
 
/
 
b
 
 antibodies. The box
shows the gating thresholds used for cell sorting, and re-
analysis of the sorted cells is shown in 
 
B.
 
 T cell–depleted
(sorted) cells were cultured for 48 h and stained again for
CD4 and CD8 versus TCR-
 
a
 
/
 
b
 
 surface markers or for
CD4 versus CD8 markers. 
 
C
 
 shows that a population of
bright CD4
 
1
 
 or CD8
 
1
 
 TCR-
 
a
 
/
 
b
 
1
 
 T cells, accounting for
12.3% of cells (enclosed in box), appeared in the cultures
after 48 h. Less than 0.01% of cells were enclosed within
the same box in 
 
B.
 
 Analysis of CD4 versus CD8 receptors
 
1
 
Abbreviations used in this paper:
 
 FBS, fetal bovine serum; HSA, heat-stable
antigen. 
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in the same cultured cells as in C showed that almost all a/b
T cells were either CD41 (8.3%, enclosed in left box) or
CD81 (5.3%; Fig. 1 D). Less than 1% of cultured cells in C
were TCR-a/b1 and CD42 and CD82. In control exper-
iments, bone marrow cells were stained as in A, and cul-
tured for 48 h without depletion of T cells by flow cytom-
etry. The latter cells were restained after culture for CD4
and CD8 versus TCR-a/b receptors, and the staining pat-
tern is shown in E. Fewer than 1% of bright CD41 or
CD81 a/b T cells were generated in these cultures.
In similar cultures, marrow cells from BALB/c mice
were stained for CD4, CD8, and TCR-a/b markers, and
T cells were depleted by flow cytometry. Fig. 1 F shows
the staining pattern of the unfractionated BALB/c marrow
cells, and G shows the reanalysis of the T cell–depleted
cells after cell sorting. Culture of the sorted cells for 48 h
generated a population of bright CD41 or CD81 a/b1 T
cells (21.0%) enclosed in the box in Fig. 1 H. Analysis of
CD4 and CD8 receptors of the cultured cells showed that
12.2% were CD41 and 8.3% were CD81 (Fig. 1 I). Stain-
ing of the control culture of unsorted marrow cells is
shown in J. Three different batches of fetal bovine serum
from the same commercial source were tested and all sup-
ported the outgrowth of CD41 and CD81 T cells. How-
ever, the vigor of outgrowth varied from z5–30% of nucle-
ated cells harvested.
T Cell Maturation Stages and Kinetics. To determine the
kinetics of T cell outgrowth from marrow cultures, sorted
CD42CD82 a/b2 marrow cells from C57BL/Ka mice
were cultured for 36, 40, 44, and 48 h, and cells were har-
vested and restained for CD4, CD8, and TCR-a/b mark-
ers at each time point as shown in Fig. 2. A and B show
that little or no bright CD41 and/or CD81 a/b1 T cells
developed after 36 h of culture, and 0.1% of the cultured
cells were enclosed in the box in B. Between 40 and 48 h,
the percentage of CD41 and/or CD81 a/b1 T cells in-
creased rapidly, and the percentages of cells enclosed in the
boxes in Fig. 2, C, D, and E were 2.5, 3.5, and 7.8%, re-
spectively. Analysis of CD4 versus CD8 markers at the later
time points showed that at 40 and 44 h (F and G), the ma-
jority of T cells were CD41CD81 (enclosed in boxes).
However, at 48 h the latter cells accounted for only 0.2%
of cultured cells (panel H). CD41 T cells were observed
also at 40 and 44 h, but a discrete population of CD81 cells
was not observed until 48 h (panel H). Fig. 2, I, J, and K show
CD4 versus CD8 receptor expression at 40, 44, and 48 h in
a repeat experiment with a more robust outgrowth of CD41
CD81 T cells. The transient appearance of CD41CD81
T cells was observed again at 40 and 44 h (27.5 and 29.6%
of cells, respectively), and the marked loss of these cells at
48 h (0.4%) was associated with the appearance of a discrete
population of CD81 T cells. At 40 h (Fig. 2 I), a discrete
population of CD41CD8med cells was observed, and at 48 h
the intensity of CD8 expression on CD41 cells was reduced
(Fig. 2 K) as reported in heterogeneous thymic stromal cell
cultures (14). The rapid development of CD41CD81 T
cells, which are the immediate precursors of CD41 and
CD81 T cells, has been described also in the thymic stro-
mal cell cultures, but the double positive T cells persisted as
the single positive T cells were generated.
Positive and Negative Selection of Bone Marrow–derived T
Cells. During thymic maturation, CD41 and CD81 T
cells expressing Vb receptors, which are reactive to endoge-
nous superantigens, undergo clonal deletion via a process of
negative selection (9, 26). The pattern of deletion of Vb re-
Figure 1. CD4, CD8, and TCR-a/b profiles of bone marrow cells be-
fore and after culture. Freshly isolated bone marrow cells from C57BL/Ka
(A) or BALB/c (F) mice were depleted of cells expressing CD4, CD8,
and TCR-a/b markers using the gating boxes in the lower left and rean-
alyzed in B and G. The depleted marrow cells were cultured for 48 h and
the bright TCR-a/b1 cells that developed are enclosed in the boxes in C
and H. The depleted cultured cells were analyzed for CD4 versus CD8
markers in D and I. Analyses of non–T cell–depleted marrow cells after
culture are shown in E and J.
Figure 2. Kinetics of development of CD41CD81, CD41, and CD81
T cells during marrow cultures. C57BL/Ka marrow cells depleted of a/b
T cells (A) were cultured, and the CD4/CD8 versus TCR-a/b profiles
are shown at 36 (B), 40 (C), 44 (D), and 48 (E) h. Boxes enclose the
newly generated T cells. Analyses of CD4 versus CD8 markers are shown
in the same cultures for 40 (F), 44 (G), and 48 (H) h, and boxes enclose
CD41CD81 T cells. A repeat experiment is shown at 40 (I), 44 (J), and
48 (K) h.1816 Alternate Pathway for T Cell Development
ceptors has been characterized for many mouse strains and
is dependent on their expression of MHC gene haplotypes
(9, 27, 28). Comparison of the C57BL (H-2b) and BALB/c
(H-2d) strains have shown that the Vb4, Vb6, Vb8.1/8.2,
and Vb9 receptors are not deleted in both strains, and the
Vb3, Vb5.1, Vb11, and Vb12 receptors are deleted in the
BALB/c but not C57BL strain (29). Vb2 receptors are de-
leted in some strains of BALB/c mice, but not others (30).
To determine whether the CD41 and CD81 T cells gener-
ated in marrow cultures undergo negative selection, the
percentage of T cells expressing nondeleted and deleted Vb
receptors was compared in both strains after harvesting cells
at 48 h (see Fig. 1). In each case, the percentage of T cells
expressing each Vb receptor was measured by two-color
analysis after staining for TCR-a/b or CD3 versus Vb re-
ceptors with the appropriate fluorochrome-conjugated
monoclonal antibodies. Since the Vb8.1/8.2 T cells repre-
sent the largest subset of nondeleted T cells in both strains,
the ratio of T cells expressing other Vb receptors versus
Vb8.1/8.21 T cells was determined to normalize the varia-
tion of the levels of all T cells generated in each culture.
Table 1 compares the mean Vbn:Vb8 ratios of T cells in
the normal spleens of C57BL/Ka and BALB/c mice in
three to seven experiments. The mean ratios of the nonde-
leted Vb receptors (Vb2, Vb4, Vb6, and Vb9) were similar
in the two strains, and the ranges were 0.13–0.45 (C57BL/
Ka) and 0.11–0.47 (BALB/c). The mean ratios of Vb re-
ceptors deleted in BALB/c mice (Vb3, Vb5.1, Vb11, and
Vb12) were uniformly reduced in BALB/c (range: 0.03–
0.08) versus C57BL/Ka (range: 0.24–0.42) spleen cells.
The ranges for the nondeleted Vb receptors in marrow cul-
ture–derived T cells from the two strains were similar, and
varied from 0.10 to 0.39 in C57BL/Ka and from 0.08 to
0.38 in BALB/c. On the other hand, the mean ratios for
deleted Vb receptors were uniformly lower again in BALB/c
mice (range: 0.05–0.12) versus that in C57BL/Ka mice
(range: 0.19–0.39).
During thymic maturation, CD41 and CD81 T cells ex-
pressing certain Vb receptors are positively selected by en-
dogenous superantigens from their CD41CD81 T cell pre-
cursors. CD41 T cells expressing Vb17a receptors are
strongly selected in I-E1 strains of mice that express the H-2q
haplotype and are weakly selected in those that express the
H-2b haplotype (14, 31, 32). Accordingly, the mean per-
centages of Vb17a1 T cells were compared in CD41CD81
T cells harvested at 40 and 44 h and in CD41 T cells har-
vested at 44 and 48 h in marrow cultures from SWR (H-2q)
and C57BL/Ka (H-2b) mice in three experiments. Table 2
shows that the mean percentage of Vb17a1 cells within the
gated CD41CD81, CD41CD8med, or CD41CD82 subsets
at 40, 44, and 48 h was ,1% in cultures of C57BL/Ka mar-
row cells. In contrast, the mean percentage of Vb17a1 cells
rose from 2.9% in the CD41CD81 subset at 40 and 44 h to
14% in the CD41CD8med subset at 44 h and 19% in the
CD41CD82 subset at 48 h in the SWR cultures.
Another indication of positive selection is the transient
appearance of the CD69 T cell activation marker on
CD41CD8med intermediary cells during maturation from
CD41CD81 precursors to their CD41CD82 progeny (33).
Accordingly, the percentage of CD691 cells was deter-
mined in the gated C57BL/Ka T cell subsets at 40, 44, and
48 h. Fig. 3 A shows that the percentage of CD691 cells
was 30.7% in the CD41CD8med subset (box 1) and 1.5% in
the CD41CD81 subset (box 2) at 40 h. At 44 h (Fig. 3 B),
the percentage of CD691 cells increased to 51.4% in the
CD41CD8med subset (box 3) and 2.8% in the CD41CD81
subset (box 4). At 48 h (Fig. 3 C), the percentage of
CD691 cells within the CD41CD82 subset (box 5) had
Table 1. Ratios of Vbn:Vb8 in Normal Spleen and Marrow Culture–derived T Cells
Vb2V b 4V b 6V b 9V b 3V b 5.1 Vb11 Vb12
C57BL Sp1* 0.26 6 0.08 0.35 6 0.11 0.45 6 0.02 0.13 6 0.06 0.30 6 0.04 0.42 6 0.07 0.37 6 0.05 0.24 6 0.08
BALB/c Sp1 0.30 6 0.02 0.28 6 0.12 0.47 6 0.03 0.11 6 0.05 0.08 6 0.03 0.05 6 0.06 0.07 6 0.05 0.03 6 0.05
C57BL MCD 0.33 6 0.02 0.39 6 0.09 0.36 6 0.10 0.10 6 0.01 0.20 6 0.01 0.39 6 0.03 0.37 6 0.04 0.19 6 0.03
BALB/c MCD 0.25 6 0.06 0.34 6 0.03 0.38 6 0.09 0.08 6 0.03 0.05 6 0.06 0.07 6 0.03 0.12 6 0.07 0.10 6 0.07
Ratio 5 %Vbn1:%Vb8.1/8.21 T cells. Mean percentage of Vb8.1/8.21 in the Spl and MCD T cells of C57BL mice was 19 6 2 and 16.5 6 0.4% re-
spectively, and for BALB/c mice was 22 6 1 and 23 6 5%, respectively. Bold shows Vb ratios indicative of superantigen-mediated deletion. Mean
and SD of three to seven replicate experiments are shown.
*Spl, spleen; MCD, marrow culture–derived.
Table 2. Positive Selection of Marrow Culture–derived T Cells
T cell subset
Percentage of Vb17a1 T cells*
C57BL/Ka (H-2b) SWR (H-2q)
CD41CD81 (40 h) 0.6 6 0.2 2.9 6 0.5
CD41CD81 (44 h) 0.6 6 0.1 2.9 6 0.5
CD41CD8med (44 h) 0.4 6 0.1 14 6 3
CD41CD82 (48 h) 0.6 6 0.3 19 6 3
*Percentage of Vb17a1 cells after gating on T cell subset. Mean and SD
of three replicate experiments are shown for each strain.1817 García-Ojeda et al.
fallen to 5.2% and was 3.7% in the CD42CD81 subset (box
6). Stages of thymic development between the TCRlo dou-
ble positive and the TCRhi single positive cells are CD691
in mice, and are similar to the bone marrow T cell devel-
opment described here (14).
Other Surface Markers on CD41 and CD81 T Cells Cul-
tured from Bone Marrow. Sorted CD42CD82 a/b2 mar-
row cells from C57BL/Ka mice were cultured for 48 h as
before, and the a/b1 T cells were counterstained for a va-
riety of other markers as shown in Fig. 4. In panels A–L,
cultures were gated for a/b1 cells and one- or two-color
analysis of other markers are shown. Almost all of the a/b1
T cells expressed the other usual T cell markers CD3,
CD2, CD5, and Thy1.2 at bright staining levels (A–D; solid
lines). The intensity of staining of these markers, as well as
CD4 and CD8, was similar to that of splenic T cells as
shown in Table 3. Heterogeneous staining for both L-selec-
tin (CD62L) and CD44 was observed in both cultured and
splenic T cells (E and F). Two-color analysis resolved sev-
eral discrete populations of T cells as shown in G and H.
Two subsets of CD44hi cells that stained with either bright
or intermediate intensity for CD62L are enclosed in the
box in H, and accounted for 5.8% of T cells. Less than 1%
of the normal splenic T cells were TCR-a/b1CD44hi
CD62L1, and no discrete contours for this CD44hi subset
were observed (G). The remaining CD62L1 cells showed a
staining intensity that was similar to that of normal splenic
T cells (Table 3) with a minor population of CD44int cells,
and a major population of CD44dull/2 cells, reported to be
virgin T cells (34). Further experiments showed that the
CD44hi subset in the cultured marrow cells expressed
CD161 also (I). The remaining cultured cells were CD162.
Almost all of the CD81 a/b T cells derived from the mar-
row cultures expressed both the CD8a and CD8b markers,
and few if any showed the CD8a/a phenotype (J). Less
than 2% of the cultured T cells exceeded the background
staining for the CD25 or NK1.1 markers (K and L) found
on activated or NK1.11 T cells (35, 36). Markers of imma-
ture thymocytes (HSA and cKit), which are not present on
single positive CD41 and CD81 thymic T cells, were also
not present on the cultured marrow T cells (M and N).
The staining of conventional markers of B cells, granulo-
cytes, macrophages, and erythroid cells (B220, GR-1,
Figure 3. Changes in the expression of CD69 on T cell subsets during
marrow cultures. C57BL/Ka marrow cells were depleted of a/b T cells
and cultured for 40 (A), 44 (B), and 48 (C) h as was shown in Fig. 2, F–H.
Gated CD41CD8med or CD41CD82 cells (boxes 1, 3, and 5) or CD41
CD81 cells (boxes 2 and 4) or CD42CD81 cells (box 6) were analyzed
for the expression of CD69. The profiles and percentages of CD691 cells
in each box are shown in corresponding panels 1–6. Shaded areas show
the CD691 cells.
Figure 4. Surface markers on CD41 and CD81 T cells harvested at 48 h
from C57BL/Ka marrow cultures. After gating of a/b1 cells, single color
profiles for CD3, Thy1.2, CD5, CD2, CD62L, and CD44 receptors are
shown in A–F (solid lines). Normal spleen T cell profiles are shown for
comparison in C, E, and F (broken lines). Two-color profiles for CD44
versus CD62L receptors on gated normal spleen cells and on gated mar-
row-cultured cells are compared in G and H, respectively. In addition,
the profile for CD44 versus CD16 on gated marrow cultured cells is
shown in I. A two-color profile for CD8a versus CD8b receptors on
a/b1-gated marrow cultured cells is shown in J. One-color profiles for
CD25, NK1.1, HSA, cKit, B220, Gr-1, Mac-1, and Ter119 markers on
a/b1-gated marrow-cultured cells are shown in K–R.
Table 3. Mean Channel Intensity Comparison between Normal Spleen and Marrow Culture–derived T Cells
TCR-a/b CD2 CD3 CD4 CD5 CD8 CD62L Thy 1.2
C57BL Spl* 172.2 144.2 95.3 125.8 166.3 130.0 137.1 200.8
C57BL MCD 172.8 143.1 95.1 121.6 169.4 123.1 131.8 200.5
Values indicate mean channel intensity of fluorescence for each receptor. One-color analysis was perfromed after gating on TCR-a/b1 cells for all
receptors other than TCR-a/b itself.
*Spl, spleen, MCD, marrow culture–derived.1818 Alternate Pathway for T Cell Development
Mac-1, and Ter119) were not above background on the
marrow-derived T cells (O–R).
Inhibition of T Cell Maturation by Mature Cells. Since the
outgrowth of the bright CD41 and CD81 T cells from cul-
tures shown in Fig. 1 was dependent upon depletion of
marrow T cells before culture, several experiments were
performed to determine whether the addition of T cells to
T cell–depleted cultures prevented the outgrowth of the
bright T cells. Fig. 5, A–D shows an experiment in which
C57BL/Ka marrow cells were stained for CD4, CD8, and
TCR-a/b markers, and sorted into CD42CD82 a/b2
and  a/b1 cells as shown by the gating thresholds of boxes
1 and 2 (left and right), respectively, in Fig. 5 A. Reanalysis
of the cells in box 1 are shown in B, and culture of 4 3 106
of the depleted marrow cells and restaining are shown in C.
Bright CD41 or CD81 a/b1 T cells enclosed in the box of
C accounted for 13.4% of cultured cells at 48 h. Addition
of 3 3 105 sorted TCR-a/b1 T cells from box 2 of A to 4
3 106 depleted marrow cells from box 1 of A at the initia-
tion of the culture inhibited the outgrowth of bright CD41
or CD81 a/b T cells after the 48-h culture, and ,1% of
the cultured cells are enclosed in the box shown in D.
To determine whether the inhibition was mediated by
CD41 and CD81 a/b T cells and/or CD42CD82 a/b T
cells, subsequent experiments were performed in which
C57BL/Ka marrow cells were sorted using threshold gates
shown in Fig. 5 E. Box 1 (left) enclosed CD42CD82 a/b2
marrow cells, box 2 (upper right) enclosed CD41 and CD81
a/b1 T cells, and box 3 (lower right) enclosed CD42CD82
a/b1 T cells. Fig. 5 F shows the reanalysis of cells from
box 1 before culture, and G shows the restaining after cul-
ture. Bright CD41 and CD81 a/b T cells accounted for
14% of cultured cells (enclosed in the box in G). In further
experiments, 0.3 3 105 T cells from box 2 or 2 3 105 from
box 3, (Fig. 5 E) were added to 4 3 106 depleted marrow
cells in box 1, and the combined cells were cultured for 48 h.
Fig. 5, H and I, show the staining of the cultured cells with
CD41 and CD81 or CD42CD82 T cells added back, respec-
tively. The boxes in H and I enclosed ,1% of bright cells.
Thus, the CD41 and/or CD81 a/b1 T cells, as well as
CD42CD82 a/b1 T cells, from the marrow markedly in-
hibited the outgrowth of bright T cells from the marrow
cultures.
NK1.11 T cells have been reported to have an unusual
cytokine secretion pattern and Va and Vb repertoire (20,
37, 38), and their percentage among T cells is increased in
the marrow as compared to the spleen and thymus (39).
We tested the ability of NK1.11 and NK1.12 marrow T
cells to inhibit the outgrowth of bright CD41 and CD81 T
cells from the marrow cultures. Fig. 5 J shows C57BL/Ka
marrow cells stained for NK1.1 and TCR-a/b surface
markers. Box 1 (left) encloses TCR-a/b2 NK1.12 marrow
cells. Boxes 2 and 3 ( upper and lower right) enclose the
TCR-a/b1 NK1.11 and TCR-a/b1 NK1.12 T cells, re-
spectively. Reanalysis of the sorted cells within box 1 is
shown in Fig. 5 K. Culture of the latter cells for 48 h, and
staining for CD4, CD8, and TCR-a/b markers after cul-
ture is shown in panel L. Bright CD41 or CD81 a/b1 T
cells (enclosed in box) represented 22.3% of the harvested
cells. Addition of 0.5 3 105 of the sorted T cells from box
2 or 2.5 3 105 from box 3 from J were added to 4 3 106
Figure 5. Add back of marrow T cells to T cell–depleted marrow cul-
tures. Freshly isolated marrow cells (A) were sorted using the gating boxes
1 and 2, and reanalysis of T-depleted cells in box 1 are shown in B. After
48 h of culture of cells in B, newly formed T cells are enclosed in the box
in C. Culture of combined cells from boxes 1 and 2 are shown in D.
Marrow cells were also sorted for CD41 or CD81 TCR-a/b1 (E, box 2),
or CD42CD82 TCR-a/b1 (E, box 3) T cells. F and G show T cell-
depleted marrow cells before and after culture. H and I show T cell-
depleted marrow cells cultured in combination with cells from E, box 2
or 3, respectively. Marrow cells were also gated for NK1.12 TCR-a/b2
(J, box 1), NK1.11 TCR-a/b1 (J, box 2), and NK1.12TCR-a/b1 (J,
box 3) subsets, respectively. Sorted NK1.12TCR-a/b1 (K) cells were
cultured alone (L), or with cells from box 2 (M) or box 3 (N).
Figure 6. Addition of lymph node T cells or Thy1.21a/b2 marrow
cells to marrow cultures. Freshly isolated marrow cells from Ly5.1 con-
genic mice were depleted of T cells by sorting (A and B), and profiles of
CD4/CD8 versus Ly5.2 markers are shown after culture (C). The Ly5.1
versus 5.2 profile of lymph node cells from Ly5.2 congenic mice after gat-
ing on TCR-a/b1 cells is shown in D. Gated TCR-a/b1 cells from D
were added to T-depleted marrow cells (B) and cultured for 48 h (E).
CD41 and CD81 T cells that are Ly5.22 or Ly5.21 are enclosed in left
and right boxes, respectively. The profile of TCR-a/b versus Thy1.2
markers on C57BL/Ka marrow is shown in F, and sorted Thy1.22 TCR-
a/b2 cells were reanalyzed (G). Cells from G were cultured alone and
analyzed (H) or cultured in combination with Thy1.21 TCR-a/b2 cells (I).1819 García-Ojeda et al.
cells from box 1, and the staining patterns of the cultured
cells are shown in M and N, respectively. The combined
cell cultures contained ,1% of bright CD41 and CD81 a/
b1 T cells (enclosed in boxes) after 48 h.
Since CD41 and CD81, CD42CD82, NK1.11, and
NK1.12 marrow T cells strongly inhibited the outgrowth
of bright T cells, we determined whether the inhibitory
function was a unique property of marrow T cells or a
property of peripheral T cells as well. Accordingly, sorted
CD41 and CD81 T cells from the lymph nodes of C57BL/6
mice expressing the Ly5.2 marker were added to T cell–
depleted marrow cultures from C57BL/6 congenic mice
expressing the Ly5.1 marker. Fig. 6 A shows the staining
pattern of the marrow cells from Ly5.1 mice for CD4 and
CD8 versus TCR-a/b markers, and reanalysis of sorted
CD42CD82 a/b2 marrow cells is shown in B. Cells (4 3
106) in Fig. 6 B were cultured for 48 h and stained for the
Ly5.2 versus CD4 and CD8 markers. Bright CD41 and
CD81 a/b1 T cells (16.1%) were generated from these
cultures, and, as expected, these cells did not express the
Ly5.2 marker (see box in C).
In subsequent experiments, 1.2 3 105 sorted Ly5.21 a/b1
T cells from the lymph nodes of congenic Ly5.2 mice were
added to 4 3 106 T cell–depleted marrow cells from Ly5.1
mice and cultured for 48 h. Fig. 6 D shows the staining
pattern of the lymph node cells for Ly5.1 versus Ly5.2
markers after gating on TCR-a/b1 cells. As expected,
most all of these cells expressed the Ly5.2 marker (enclosed
in box). Sorted a/b1 T cells from D were added to those
from B, and the cultured cells were stained for Ly5.2 versus
CD4 and CD8 markers as shown in E. The latter cells con-
tained ,1% of CD41 and CD81 cells (enclosed in left box)
derived from the Ly5.11 marrow cells, but included a dis-
crete population of CD41 and CD81 Ly5.21 T cells
(19.2% enclosed in right box) derived from the added
lymph node cells. Comparison of Fig. 6, C with E, indi-
cated that the addition of the lymph node T cells to mar-
row cultures markedly inhibited the outgrowth of Ly5.22
T cells derived from the marrow.
The experimental results showed that all of the sorted
mature T cells from the marrow and lymph nodes that ex-
pressed the TCR-a/b were able to inhibit the outgrowth
of bright CD41 and CD81 T cells from the marrow cul-
tures. Bone marrow cells which express the Thy1.21
TCR-a/b2 phenotype of the earliest T cell precursors in
the thymus (40, 41) also were tested for the ability to in-
hibit the marrow cultures. C57BL/Ka marrow cells were
stained for Thy1.2 versus TCR-a/b markers. Fig. 6 F
showed that bright Thy1.21 cells that are bright a/b1 T
cells (enclosed in box 2, upper right) account for 1.3% of
cells, and bright Thy1.21 cells that are dull or negative for
the TCR-a/b marker (enclosed in box 3, lower right) ac-
count for 1.5% of cells. The Thy1.21 a/b2 cells were
added to C57BL/Ka marrow cells, which were stringently
depleted of Thy1.11 and TCR-a/b1 cells as shown in Fig.
6 G. The latter cells (4 3 106) were cultured for 48 h as in
previous experiments. Staining of the cultured cells from G
for CD4, CD8, and TCR-a/b receptors showed that a
population of bright CD41 and/or CD81 a/b1 T cells
were present and accounted for 18% of cells (enclosed in
box) in H. Fig. 6 I shows that the addition of 3 3 105
Thy1.21 a/b2 cells (Fig. 6 F, box 3) to the cultures did
not inhibit the outgrowth of the bright CD41 and/or
CD81  a/b1 T cells at 48 h, and 19.4% of the cultured cells
are enclosed in the box. Thus, inhibition was associated
with the expression of the TCR-a/b, but not the Thy1.2
marker.
Discussion
Several lines of evidence have supported the notion that
a/b T cells can develop in the absence of the thymus mi-
croenvironment, including studies of in vivo T cell devel-
opment in nontransgenic and TCR-a/b transgenic athy-
mic nude mice, and in irradiated thymectomized fetal liver,
bone marrow, or hematopoietic stem cell–reconstituted
mice (15, 18, 19, 23, 24). In vitro studies of T cell develop-
ment have demonstrated that single cell agar gel cultures of
marrow precursors, or dispersed cultures of hematopoietic
progenitor cells, can give rise to T cells (42, 43). Our pre-
vious reports of the generation of T cells from dispersed
bone marrow cultures showed that mature T cells must be
stringently depleted from nontransgenic or TCR-a/b trans-
genic marrow cells before culture to allow for in vitro T cell
maturation (19, 24). In the latter studies, almost all the T cells
generated within 48 h expressed the CD42CD82 a/b1 sur-
face phenotype, and few if any CD41 or CD81 T cells were
observed (19, 24). In this study, almost all the T cells gen-
erated in the marrow cultures were CD41 or CD81 at 48 h,
using a different source of FBS to supplement the culture
medium. The nature of the substances in the different sources
of serum that dramatically alter the maturation of T cells is
unknown. Candidate molecules include thymic hormones
that have been shown to facilitate T cell maturation (44).
Our experiments show that few if any a/b1 T cells were
generated in the T cell–depleted marrow cultures during
the first 36 h, and a rapid maturation of CD41 and CD81
(single positive) T cells occurred during the ensuing 12 h.
The first expression of bright TCR expression occurred at
40 h, and was predominantly on CD41CD81 (double pos-
itive) T cells and on a minority of CD41CD8med T cells.
The transition from the predominant double positive T
cells at 40 h to the almost complete predominance of single
positive T cells at 48 h recapitulates the transition from
double positive to single positive T cells in the thymus (1,
2). In the heterogeneous thymic stromal cell culture sys-
tem, the transition from CD42CD82CD32 thymus pre-
cursor cells to single positive cells also occurs in 48 h, and,
as in the bone marrow cultures, the transition from double
positive to single positive cells occurs within 12 h. In both
the thymic stromal and bone marrow cultures, the appear-
ance of CD41CD8med T cells preceded that of the CD81 T
cells (14). It is likely that rearrangements of the TCR genes
occurred in the marrow cultures before TCR expression at1820 Alternate Pathway for T Cell Development
40 h, since previous studies showed that no functional rear-
rangements of the TCR-b chain genes were detected in T
cell–depleted marrow cultures at time zero due to the pres-
ence of stop codons in the junctions or out of frame read-
ing of the Jb segments. However, functional rearrange-
ments were plentiful at 48 h (19). Thus, the outgrowth of
T cells in these cultures does not represent the upregulation
of expression of previously rearranged TCR genes. A simi-
lar robust outgrowth of extrathymically derived CD41
CD81 T cells in the peripheral lymphoid tissues has been
observed in athymic mice reconstituted with bone marrow
obtained from mice expressing the bovine oncostatin-M
transgene under the control of the p56lck proximal pro-
moter (45). The alternate pathway described here is a likely
source for the development of the transgenic T cells.
As in the thymic stromal cultures (14), evidence for pos-
itive selection of the CD41CD82 T cells was obtained by
comparing their expression of Vb17a to that of the
CD41CD81 T cells in the cultures from SWR (H-2q) and
C57BL/Ka (H-2b) strains. As expected, a marked increase
in the percentage of Vb17a1 cells within the CD41CD82
as compared to the CD41CD81 subset was observed in the
SWR but not in the C57BL cultures. Additional evidence
for positive selection was the transient expression of the
CD69 activation antigen on CD41CD8med T cells at 40
and 44 h, but not on CD41CD82 at 48 h. Comparison of
superantigen-deleted and nondeleted Vb receptors on the
single positive T cells in 48-h cultures of C57BL/Ka and
BALB/c marrow cells showed that the latter cells had un-
dergone negative selection, and the pattern of Vb receptor
expression was similar to that of T cells in the spleen of
both strains.
The surface phenotype of single positive T cells gener-
ated in the marrow cultures was similar to that of mature
(HSA2) single positive T cells in the thymus and peripheral
lymphoid tissues, since the typical T cell markers Thy1.2,
CD5, CD2, and CD3 were expressed in the absence of
markers of B cells, NK cells, or other hematopoietic cells.
The marrow-derived T cells contained subsets usually asso-
ciated with virgin (CD442CD62L1) and memory
(CD441CD62L2) T cells in normal spleen (34, 46). An
unusual minor subset of CD44hiCD161CD62L1 marrow-
derived T cells was not found in the spleen, and more
closely resembles the immature CD44hi subsets of T cells in
thymus (47–49).
The marrow-derived CD81 T cells expressed both the
CD8a and CD8b chains, and few if any expressed only
CD8a/a homodimers. The expression of the latter ho-
modimers has been found on extrathymically derived
CD81TCR-a/b1 intraepithelial lymphocytes in the intes-
tines (16, 50). Since there were no surface markers on most
marrow-derived single positive T cells that clearly distin-
guished them from thymus-derived single positive T cells
in the periphery, the contribution of marrow-derived T
cells to the peripheral T cell pool in vivo is unclear. The al-
most complete absence of single positive T cells in the
spleen and lymph nodes of nude mice in the first 3 mo of
life and the slow accumulation thereafter (15) suggest that
the marrow contribution to the peripheral pool is minimal.
However, the thymus may augment the marrow produc-
tion of T cells by the secretion of humoral factors that pro-
mote T cell maturation (44). Thus, the rate of production
of single positive T cells by the marrow and their contribu-
tion to the peripheral pool of euthymic mice may not be
accurately determined by studies of athymic mice.
Several subsets of mature T cells inhibited the outgrowth
of CD41CD81, CD41, and CD81 T cells from the mar-
row cultures. Adding back sorted subsets of marrow T cells
showed that marked inhibition was achieved with CD41
and CD81, CD42CD82, NK1.11, and NK1.12 a/b1 T
cells. These a/b1 T cells prevented T cell maturation at a
ratio as low as 1:100 of sorted T cells to T cell–depleted
marrow cells. A similar low ratio of mature a/b1 T cells
obtained from the lymph nodes prevented the outgrowth
of T cells from marrow cultures. Although marrow-derived
and peripheral T cells expressing the TCR-a/b were in-
hibitory, sorted Thy1.21a/b2 marrow cells failed to in-
hibit T cell maturation. Bright Thy1.21 cells that do not
express the TCR are found in the thymus also, and are able
to differentiate into the more mature Thy1.21a/b1 thymic
T cells (49, 51, 52). The differences in the inhibitory activ-
ity of the Thy1.21a/b2 and Thy1.21a/b1 marrow cells
indicates that only mature T cells prevent marrow T cell
maturation by a feedback inhibition process. Maturation is
blocked before the double positive stage, since neither
double positive nor single positive T cells were detected at
36, 40, 44, or 48 h in the nondepleted marrow cultures
(data not shown). Feedback inhibition may contribute to
the disappearance of double positive cells at 48 h in mar-
row cultures, whereas these cells persist in thymic stromal
cell cultures (14). Alternatively, the in vitro lifespan of dou-
ble positive cells, most of which are postselected cells and
are destined to die, may be longer in heterogeneous thymic
stromal cell cultures than those in bone marrow cultures for
reasons other than feedback inhibition, e.g., the presence of
survival factors. Bone marrow and thymic stromal cell cul-
ture mixing experiments should help resolve these alterna-
tives.
Our results suggest that a microenvironment that sup-
ports CD41 and CD81 a/b1 T cell maturation from pre-
cursors is not unique to the thymus, and that the marrow
microenvironment is capable of carrying out this function,
presumably by specialized stromal cells. The predominance
of the thymus as the source of T cells in the lymphoid tis-
sues may be explained better by the differences in the regu-
lation of T cell maturation in different generative sites than
by differences in the capacities of microenvironments in
these generative sites to support maturation. In particular,
the presence of mature T cells may strongly inhibit matura-
tion in the marrow but not in the thymus. T cell matura-
tion in the marrow may be regulated in part by thymus-
derived emigrants such that the rate of marrow T cell pro-
duction and export is increased in disease states in which
mature T cells are depleted, such as acquired immunodefi-1821 García-Ojeda et al.
ciency syndrome in humans, or after myeloablation and
stem cell transplantation in hosts with poor thymic func-
tion.
Is T cell feedback inhibition of T cell development a
process limited to bone marrow cultures? The heteroge-
neous thymic stromal cell cultures (13, 14) were always ini-
tiated in the absence of mature T cells, and feedback inhi-
bition was not tested. This process might be operative also
in the thymus in situ; thymic CD42CD82CD32 cells are
located in the subcapsular cortex (1, 10, 51), whereas single
positive CD41 and CD81 T cells are in the juxtamedullary
cortex and the medulla. Thus, the separation of immature
and mature cells in the thymus could prevent short-range
inhibitory effects. However, in some circumstances acti-
vated T cells recirculate to the thymic cortex (53–55) and
may participate in negative feedback. These potential feed-
back loops in the thymus and the bone marrow in situ have
yet to be tested.
In conclusion, the microenvironment of the bone mar-
row provides necessary and sufficient signals for the matu-
ration of single positive T cells from T cell precursors in the
marrow. The process is tightly regulated by the presence of
mature T cells in the microenvironment, and appears to re-
capitulate the main elements of thymic maturation through
a double positive intermediary T cell. Differences in the
functional capacities of marrow-derived and thymus-derived
T cells remain to be elucidated.
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